Thyroid Cancer Epidemiology

• As per Surveillance, Epidemiology, and End Results (SEER), Thyroid cancer accounts for 43,800 new cases in the US, in 2022. 

• As per a study by The American Cancer Society (2022), the most recent estimates for thyroid cancer in the United States are about 43,800 new cases of thyroid cancer accounting for 11,860 cases in men and 31,940 cases in women. 

• Thyroid Cancer epidemiology is segmented as Total Thyroid Cancer Incident Cases, Thyroid Cancer Age-specific cases, Thyroid Cancer Gender-specific Cases, Thyroid Cancer Stage-specific incident cases, Thyroid Cancer Type-specific incident cases, and Total Thyroid Cancer Treated Cases in the Thyroid Cancer epidemiology report.

Request a sample to unlock the CAGR for Thyroid Cancer Epidemiology

DelveInsight's “Thyroid Cancer Epidemiology Forecast — 2034” report delivers an in-depth understanding of the disease, historical and forecasted Thyroid Cancer epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Geography Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

Study Period: 2021-2034

Unlock comprehensive insights! Click Here to Purchase the Full Report @ Thyroid Cancer Drugs Market

Thyroid Cancer Epidemiology: Disease Understanding

The DelveInsight’s Thyroid Cancer epidemiology report gives a thorough understanding of Thyroid Cancer by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. Thyroid cancer is a form of cancer that begins in the tissues of the thyroid gland. The major thyroid cancer types are differentiated (including Hürthle's papillary, follicular and papillary), medullary, anaplastic (aggressive form). Most thyroid cancers are differentiated, and when observed in the lab, the cells in these cancers appear a lot like normal thyroid tissue. Papillary cancer also termed papillary carcinomas or papillary adenocarcinomas occurs in about 8 out of 10 thyroid cancers. These cancers appear to grow very slowly and typically arise in the thyroid gland in only one lobe. Papillary cancers also spread to the lymph nodes in the neck even though they develop slowly. A few subtypes of papillary cancer are present. Of these, the most common is the follicular subtype (also called the mixed papillary-follicular variant).

Thyroid cancer can cause any of the following signs or symptoms: a lump in the neck, sometimes growing quickly along with swelling in the neck, pain in the front of the neck, trouble swallowing, etc.

Thyroid Cancer Diagnosis

The diagnosis procedure incorporates analyzing the medical history along with conducting a physical exam such as imaging tests, biopsy, blood tests, and vocal cord exam, also known as (laryngoscopy).

Tiny thyroid cancers exist undetected in the glands of as many as one-third of all adults, and the vast majority of these are never detected or cause any clinical problems. For this reason, and because tiny nodules are difficult to biopsy accurately, any nodule of less than 1 centimeter in size may not need to be further evaluated. For nodules of more than 1 centimeter, a grading system is applied and biopsy is recommended if the score indicates an appropriate level of concern. Nodules that are not judged to need biopsy may be monitored with repeat ultrasound examinations.

Thyroid Cancer Epidemiology 

The Thyroid Cancer epidemiology section provides insights about historical and current Thyroid Cancer patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

• As per Surveillance, Epidemiology, and End Results (SEER), Thyroid cancer accounts for 43,800 new cases in the US, in 2022. 

• As per a study by The American Cancer Society (2022), the most recent estimates for thyroid cancer in the United States are about 43,800 new cases of thyroid cancer accounting for 11,860 cases in men and 31,940 cases in women. 

• The disease epidemiology covered in the report provides historical as well as forecasted Thyroid Cancer epidemiology [segmented as Total Incident Cases of Thyroid Cancer, Age-specific cases of Thyroid Cancer, Gender-specific Cases of Thyroid Cancer, Stage-specific incident cases of Thyroid Cancer, Type-specific incident cases of Thyroid Cancer, and Total Treated Cases of Thyroid Cancer] in the 7MM covering the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan from 2021 to 2034.

Country Wise- Thyroid Cancer Epidemiology

This section provides a glimpse of the Thyroid Cancer epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Learn how the market will evolve and grow in the coming years:  Drugs for Thyroid Cancer

 

KOL- Views

To keep up with the current Thyroid Cancer patient pool and forecasted trend, we take KOLs and SMEs ' opinions working in the Thyroid Cancer domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate the patient pool and forecasted trend.

Scope of the Thyroid Cancer Epidemiology Report

• The report covers the descriptive overview of Thyroid Cancer, explaining their causes, symptoms, pathophysiology, and genetic basis
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan
• The report assesses the disease risk and burden and highlights the unmet needs of Thyroid Cancer
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population
• The report provides the segmentation of the disease epidemiology for 7MM by Total Incident Cases of Thyroid Cancer, Age-specific cases of Thyroid Cancer, Gender-specific Cases of Thyroid Cancer, Stage-specific incident cases of Thyroid Cancer, Type-specific incident cases of Thyroid Cancer, and Total Treated Cases of Thyroid Cancer.

Thyroid Cancer Epidemiology Report Highlights

• The companies and academics are working to assess challenges and seek opportunities that could influence Thyroid Cancer R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Thyroid Cancer 
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Thyroid Cancer Report Insights

• Patient Population
• Therapeutic Approaches

Thyroid Cancer Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Thyroid Cancer Epidemiology Segmentation

Thyroid Cancer Report Assessment

• Disease Understanding
• Current Diagnosis Practices and Guidelines
• Epidemiology Trends

Key Questions

Epidemiology Insights:

• What are the disease risk, burden, and regional/ethnic differences of Thyroid Cancer?
• What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan?
• What is the historical Thyroid Cancer patient pool in seven major markets covering the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan?
• What would be the forecasted patient pool of Thyroid Cancer in seven major markets covering the United States,EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan?
• Where will be the growth opportunities in the 7MM concerning the patient population about Thyroid Cancer?
• Out of all 7MM countries, which country would have the highest incident population of Thyroid Cancer during the forecast period (2025-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?

Reasons to buy

• The report will help in developing business strategies by understanding trends shaping and driving the Thyroid Cancer Disease market
• To understand the future market competition in the Thyroid Cancer Disease market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Thyroid Cancer Disease in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for the Thyroid Cancer Disease market
• To understand the future market competition in the Thyroid Cancer Disease market

Stay Updated for new articles @ Latest DelveInsight Blogs